Warning: The NCBI web site requires JavaScript to function. more...
Proteomic analysis of tumor necrosis factor-alpha resistant human breast cancer cells reveals a MEK5/Erk5-mediated epithelial-mesenchymal transition phenotype.
Zhou C, Nitschke AM, Xiong W, Zhang Q, Tang Y, Bloch M, Elliott S, Zhu Y, Bazzone L, Yu D, Weldon CB, Schiff R, McLachlan JA, Beckman BS, Wiese TE, Nephew KP, Shan B, Burow ME, Wang G.
Breast Cancer Res. 2008;10(6):R105. Epub 2008 Dec 16.
Related citations
Identification of mitogen-activated protein kinase kinase as a chemoresistant pathway in MCF-7 cells by using gene expression microarray.
Weldon CB, Scandurro AB, Rolfe KW, Clayton JL, Elliott S, Butler NN, Melnik LI, Alam J, McLachlan JA, Jaffe BM, Beckman BS, Burow ME.
Surgery. 2002 Aug;132(2):293-301.
MEK5 is activated by shear stress, activates ERK5 and induces KLF4 to modulate TNF responses in human dermal microvascular endothelial cells.
Clark PR, Jensen TJ, Kluger MS, Morelock M, Hanidu A, Qi Z, Tatake RJ, Pober JS.
Microcirculation. 2011 Feb;18(2):102-17. doi: 10.1111/j.1549-8719.2010.00071.x.
The actin filament cross-linker L-plastin confers resistance to TNF-alpha in MCF-7 breast cancer cells in a phosphorylation-dependent manner.
Janji B, Vallar L, Al Tanoury Z, Bernardin F, Vetter G, Schaffner-Reckinger E, Berchem G, Friederich E, Chouaib S.
J Cell Mol Med. 2010 Jun;14(6A):1264-75. Epub 2009 Oct 3.
Epithelial-to-mesenchymal transition and resistance to ingenol 3-angelate, a novel protein kinase C modulator, in colon cancer cells.
Ghoul A, Serova M, Astorgues-Xerri L, Bieche I, Bousquet G, Varna M, Vidaud M, Phillips E, Weill S, Benhadji KA, Lokiec F, Cvitkovic E, Faivre S, Raymond E.
Cancer Res. 2009 May 15;69(10):4260-9. Epub 2009 May 5.
Involvement of Pin1 induction in epithelial-mesenchymal transition of tamoxifen-resistant breast cancer cells.
Kim MR, Choi HK, Cho KB, Kim HS, Kang KW.
Cancer Sci. 2009 Oct;100(10):1834-41. Epub 2009 Jul 24.
Benzyl isothiocyanate inhibits epithelial-mesenchymal transition in cultured and xenografted human breast cancer cells.
Sehrawat A, Singh SV.
Cancer Prev Res (Phila). 2011 Jul;4(7):1107-17. Epub 2011 Apr 4.
Role of nuclear factor kappa B and reactive oxygen species in the tumor necrosis factor-alpha-induced epithelial-mesenchymal transition of MCF-7 cells.
Dong R, Wang Q, He XL, Chu YK, Lu JG, Ma QJ.
Braz J Med Biol Res. 2007 Aug;40(8):1071-8.
Interleukin-6 induces an epithelial-mesenchymal transition phenotype in human breast cancer cells.
Sullivan NJ, Sasser AK, Axel AE, Vesuna F, Raman V, Ramirez N, Oberyszyn TM, Hall BM.
Oncogene. 2009 Aug 20;28(33):2940-7. Epub 2009 Jul 6.
Inhibition of epithelial to mesenchymal transition in metastatic breast carcinoma cells by c-Src suppression.
Liu X, Feng R.
Acta Biochim Biophys Sin (Shanghai). 2010 Jul;42(7):496-501. Epub 2010 Jun 10.
p70 S6 kinase promotes epithelial to mesenchymal transition through snail induction in ovarian cancer cells.
Pon YL, Zhou HY, Cheung AN, Ngan HY, Wong AS.
Cancer Res. 2008 Aug 15;68(16):6524-32.
Stat3 upregulates MEK5 expression in human breast cancer cells.
Song H, Jin X, Lin J.
Oncogene. 2004 Oct 28;23(50):8301-9.
Keratinocyte growth factor (KGF) induces tamoxifen (Tam) resistance in human breast cancer MCF-7 cells.
Chang HL, Sugimoto Y, Liu S, Ye W, Wang LS, Huang YW, Lin YC.
Anticancer Res. 2006 May-Jun;26(3A):1773-84.
Krüppel-like factor 8 induces epithelial to mesenchymal transition and epithelial cell invasion.
Wang X, Zheng M, Liu G, Xia W, McKeown-Longo PJ, Hung MC, Zhao J.
Cancer Res. 2007 Aug 1;67(15):7184-93.
Progesterone reverses the mesenchymal phenotypes of basal phenotype breast cancer cells via a membrane progesterone receptor mediated pathway.
Zuo L, Li W, You S.
Breast Cancer Res. 2010;12(3):R34. Epub 2010 Jun 11.
Rb depletion results in deregulation of E-cadherin and induction of cellular phenotypic changes that are characteristic of the epithelial-to-mesenchymal transition.
Arima Y, Inoue Y, Shibata T, Hayashi H, Nagano O, Saya H, Taya Y.
Cancer Res. 2008 Jul 1;68(13):5104-12.
Buthionine sulfoximine sensitizes antihormone-resistant human breast cancer cells to estrogen-induced apoptosis.
Lewis-Wambi JS, Kim HR, Wambi C, Patel R, Pyle JR, Klein-Szanto AJ, Jordan VC.
Breast Cancer Res. 2008;10(6):R104. Epub 2008 Dec 5.
ERalpha signaling through slug regulates E-cadherin and EMT.
Ye Y, Xiao Y, Wang W, Yearsley K, Gao JX, Shetuni B, Barsky SH.
Oncogene. 2010 Mar 11;29(10):1451-62. Epub 2010 Jan 18.
Multidrug resistance in breast cancer cells during epithelial-mesenchymal transition is modulated by breast cancer resistant protein.
Chen WJ, Wang H, Tang Y, Liu CL, Li HL, Li WT.
Chin J Cancer. 2010 Feb;29(2):151-7.
The ERK5 and ERK1/2 signaling pathways play opposing regulatory roles during chondrogenesis of adult human bone marrow-derived multipotent progenitor cells.
Bobick BE, Matsche AI, Chen FH, Tuan RS.
J Cell Physiol. 2010 Jul;224(1):178-86.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on